Tumor Markers. Number 0. Policy. Aetna considers any of the following serum tumor markers for the stated indication medically necessary Prostate specific antigen PSA for prostate cancer screening see CPB 0. Prostate Cancer Screening, staging, monitoring response to therapy, and detecting disease recurrence. Carcinoembryonic antigen CEA for any off the following As a preoperative prognostic indicator in members with known colorectal carcinoma or mucinous appendiceal carcinoma when it will assist in staging and surgical treatment planning or Pancreatic cyst fluid CEA for distinguishing mucinous from non mucinous malignant pancreatic cysts or. To detect asymptomatic recurrence of colorectal cancer after surgical andor medical treatment for the diagnosis of colorectal cancer not as a screening test for colorectal cancer or. To monitor response to treatment for metastatic colorectal cancer. CEA for cholangiocarcinoma, gallbladder cancer, lung cancer, medullary thyroid cancer, metastatic breast cancer, mucinous ovarian cancer, and occult primary. CEA for evaluation of jaundice, abnormal liver function tests LFTs or for obstructionabnormality on liver imaging. HIAA for neuroendocrine tumors. ALK gene fusion as a molecular biomarker in non small cell lung cancer. ALK gene rearrangement for diffuse large B cell lymphoma, peripheral T cell lymphoma, and post transplant lymphoproliferative disorder. Virus Cultivation In Cell Culture. ALK translocations for selecting candidates for crizotinib Xalkori in inflammatory myofibroblastic tumor. Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online. Easily share your publications and get. APC for familial adenomatous polyposis when criteria are met in CPB 0. Genetic Testing and for desmoid fibromatosis experimental for other indications. Afirma Thyroid FNA analysis for assessing fine needle aspiration samples from thyroid nodules that are indeterminate experimental for other indications. Repeat testing is considered experimental and investigational. Alpha fetoprotein AFP for the following indications hepatocellular carcinoma mediastinal mass ovarian cancer pelvic mass testicular cancer testicular mass thymic carcinoma and thymoma. Alfa fetoprotein AFP for testing for hepatocellular carcinoma in hepatitis B carriers, or for persons with cirrhosis and one or more of the following risk factors alcohol use alpha 1 antitrypsin deficiency Asian female at least 5. Asian male at least 4. HCC genetic hemochromatosis hepatitis C nonalcoholic steatohepatitis and stage 4 primary biliary cirrhosis. Alpha fetoprotein AFP serial measurements to diagnose germ cell tumors in members with adenocarcinoma, or carcinoma not otherwise specified, involving mediastinal nodes or the diagnosis and monitoring of hepatocellular carcinoma e. No more missed important software updates UpdateStar 11 lets you stay up to date and secure with the software on your computer. Complete aeronautical information about Harold Davidson Field Airport Vermillion, SD, USA, including location, runways, taxiways, navaids, radio. Meter Source Book Summer Fall 2015 Suwanee, GA 30024 Contact name Thomas J. Klatt Phone 770 9325000 URL manufacturer of wing closure brushes,metal backed. Biographies Bios are in Alphabetical Order Click Picture to Enlarge Barry Abrams Barry Abrams in Saigon, at left, with his good friend, John Mikesch then Barry in. I. D. Systems acquires Keytroller, a manufacturer and marketer of electronic products for managing forklifts, construction vehicles, and other industrial. The Cloning Blues trope as used in popular culture. In Speculative Fiction, being a clone absolutely sucks. Its enough to make a clone sing the blues. Number 0352. Policy. Aetna considers any of the following serum tumor markers for the stated indication medically necessary Prostatespecific antigen PSA for. INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY ENVIRONMENTAL HEALTH CRITERIA 167 ACETALDEHYDE This report contains the collective views of an international. Automated Activation Vermillion' title='Automated Activation Vermillion' />BCRABL fluorescent in situ hybridization FISH for lymphoblastic lymphoma, acute myeloid leukemia, acute lymphocytic leukemia and chronic myelogenous leukemia experimental for other indications. Beta 2 microglobulin B2. M for multiple myeloma, non Hodgkins lymphoma and Waldenstrms macroglobulinemia lymphoplasmacytic lymphoma. BRAF V6. 00 mutation for indeterminate thyroid nodules, hairy cell leukemia gastrointestinal stromal tumors Lynch syndrome testing for persons meeting criteria in CPB 1. Genetic Testing melamoma for vemurafenib, dabrafenib, and trametinib see CPB 0. Pharmacogenomic and Pharmacodynamic Testing and colorectal cancer if KRAS nonmutated experimental for other indications. Breast Cancer Index. Breast cancer is nonmetastatic node negative and. Breast tumor is estrogen receptor positive and. Breast tumor is HER2 receptor negative and. Adjuvant chemotherapy is not precluded due to any other factor e. Member and physician prior to testing have discussed the potential results of the test and agree to use the results to guide therapy. Cancer antigen 1. CA 1. 25 levels for any of the following As a preoperative diagnostic aid in women with ovarian masses that are suspected to be malignant, such that arrangements can be made for intraoperative availability of a gynecological oncologist if the CA 1. As a screening test for ovarian cancer when there is a family history of hereditary ovarian cancer syndrome a pattern of clusters of ovarian cancer within two or more generations, where testing is performed concurrently with transvaginal ultrasound and prophylactic salpingo oophorectomy has not been performed. For this indication, screening is considered medically necessary every six months beginning at 3. Diagnosis of ovarian cancer in women with new symptoms bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, or urinary frequency and urgency that have persisted for three or more weeks, where the clinician has performed a pelvic and rectal examination and suspects ovarian cancer or. In members with adenocarcinoma of unknown primary, to rule out ovarian cancer or. In members with known ovarian cancer, as an aid in the monitoring of disease, response to treatment, detection of recurrent disease, or assessing value of performing second look surgery. CA 1. 5 3 Serial measurements of CA 1. CA 2. 7 2. 9 or Truquant RIA in following the course of treatment in women diagnosed with breast cancer, especially advanced metastatic breast cancer an increasing CA 1. CA 1. 9 9 to monitor the clinical response to therapy or detect early recurrence of disease in members with known gastric cancer, pancreatic cancer, gallbladder cancer, cholangiocarcinoma or adenocarcinoma of the ampulla of Vater. CA 1. 9 9 to rule out cholangiocarcinoma in persons with primary sclerosing cholangitis undergoing liver transplantation. CA 1. 9 9 for evaluation of jaundice, abnormal liver function tests LFTs or obstructionabnormality on imaging. CA 1. 9 9 as a tumor marker for mucinous appendiceal carcinoma. CALCA calcitonin expression for medullary thyroid cancer or for adenocarcinoma or anaplasticundifferentiated tumors of the head and neck. CALB2 calretinin expression for lung cancer and occult primary. CD 2. 5, for determining eligibility for denileukin diftitox Ontak treatment. CD 3. 1 immunostaining, for diagnosis of angiosarcoma. CD 3. CD3. 3 gemtuzumab, Mylotarg treatment. CD 5. CD5. 2 alemtuzumab, Campath treatment. CD1. Gleevec.    CHGA Chromogranin A expression for neuroendocrine tumors, non small cell lung cancer, Merkel cell carcinoma and occult primary. Cyclin D1, for diagnosis and predicting disease recurrence of mantle cell lymphoma. Decision. Dx UM Castle Biosciences, Phoenix, AZ for risk stratification of persons with localized uveal melanoma. Endo. Predict also known as 1. Breast cancer is nonmetastatic node negative and. Breast tumor is estrogen receptor positive and. Breast tumor is HER2 receptor negative and. Adjuvant chemotherapy is not precluded due to any other factor e. Member and physician prior to testing have discussed the potential results of the test and agree to use the results to guide therapy. Epidermal growth factor receptor EGFR mutation testing for predicting response to EGFR targeting tyrosine kinase inhibitors erlotinib Tarceva, gefitinib Iressa, afatinib Gilotrif in non small cell lung cancer. FLT3 gene mutation testing for acute myeloid leukemia AML.